National Health Act 1953 Amendment determination under paragraph 98C(1)(b) conditions (No. PB 11 of 2008) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 11 of 2008
Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953
I, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.
Dated 14 December 2007
STEPHEN DELLAR
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — conditions
1 Commencement
This instrument commences on 1 January 2008.
2 Amendment of PB 52 of 2007
Schedule 1 amends PB 52 of 2007.
Schedule 1 Amendments
[1] Schedule 4, item dealing with Oestradiol
omit from the column headed “Form (strength, type, size, etc.)”:
| Transdermal patches 3.28 mg, 8 |
| Transdermal patches 4.33 mg, 8 |
| Transdermal patches 6.57 mg, 8 |
| Transdermal patches 8.66 mg, 8 |
[2] Schedule 4, item dealing with Pilocarpine
omit from the column headed “Form (strength, type, size, etc.)”:
| Eye drops containing pilocarpine hydrochloride 5 mg per mL, 15 mL |
0
0
0